Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Nasdaq

Peering Into Aterian Inc. - Common Stock's Recent Short Interest

Aterian Inc. - Common Stock's (NASDAQ:ATER) short percent of float has risen 8.86% since its last report. The company recently reported that it has 9.86 million shares sold short, which is 19.05% of all regular shares that are available for trading.

Benzinga

Quantum Completes Raising $67.5M Via Oversubscribed Rights Offering

Quantum Corporation (NASDAQ:QMCO) completed raising $67.5 million by selling 30 million shares in an oversubscribed rights offering. All eligible directors and executive officers purchased 0.14 million shares. Quantum looks to use the offering proceeds for debt repayment of $20.0 million and improve its balance sheet strength, and for working capital and other general…

Benzinga

BZ Chart Of The Day: Where Will The AMD Bloodbath End?

If shares of Advanced Micro Devices, Inc. (NASDAQ: AMD) continue to drop, there’s a chance they find support around the $73 level. This could put an end to the selloff.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Borqs Collaborates With Qualcomm and Others To Tap Indian, Southeast Asian E-Bike Market

Borqs Technologies, Inc (NASDAQ:BRQS) collaborated with QUALCOMM Incorporated (NASDAQ:QCOM) and other major chipset vendors to engage in the R&D and sales of automobile telematics products primarily for the India and Southeast Asia markets. The products include an in-vehicle-infotainment system (IVI) and Telematics Control Unit (TCU) for two and three-wheelers – also called electric scooters…

Benzinga

First Patient Dosed in Citius Pharma's Phase 2b Study of Halo-Lido for the Prescription Treatment of Hemorrhoids

Citius Pharmaceuticals, Inc. (NASDAQ: CTXR) announced enrolment of first patient in the Phase 2b clinical study of Halo-Lido for the treatment of hemorrhoids.

Benzinga

After Bristol Myers Cuts Ties, Nektar Implements Cost Restructuring

Nektar Therapeutics (NASDAQ:NKTR) announced a new strategic plan to prioritize key research and development efforts and cut 70% of its workforce, including several changes to its executive team. Dimitry Nuyten, Nektar's Chief Medical Officer, will step down from his position following June 2022. He will be succeeded by Brian Kotzin, Nektar's Head of…

Benzinga

Why Nvidia Shares Are Falling

Shares of technology and software companies, including NVIDIA Corporation (NASDAQ: NVDA), are trading lower amid overall market weakness. Concerns over future Fed rate hikes have weighed on growth sectors while economic slowdown concerns have pressured market sentiment.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Upwork's Earnings Outlook

Upwork (NASDAQ:UPWK) is set to give its latest quarterly earnings report on Wednesday, 2022-04-27. Here's what investors need to know before the announcement. Analysts estimate that Upwork will report an earnings per share (EPS) of $-0.13.

Benzinga

Churchill Downs's Earnings: A Preview

Churchill Downs (NASDAQ:CHDN) is set to give its latest quarterly earnings report on Wednesday, 2022-04-27. Here's what investors need to know before the announcement. Analysts estimate that Churchill Downs will report an earnings per share (EPS) of $1.06.

Benzinga

What's Going On With Tesla Shares Today?

Tesla Inc (NASDAQ: TSLA) shares are trading lower by 9.32% at $904.96. Weakness is possibly due to continued overall market weakness, concerns China's COVID outbreak could impact the company's China operations and concerns over the impact of CEO Elon Musk acquiring Twitter.

Benzinga

Earnings Preview: Align Tech

Align Tech (NASDAQ:ALGN) is set to give its latest quarterly earnings report on Wednesday, 2022-04-27. Here's what investors need to know before the announcement. Analysts estimate that Align Tech will report an earnings per share (EPS) of $2.23.

Benzinga

Analyst Ratings for Scientific Games

Scientific Games (NASDAQ:SGMS) has observed the following analyst ratings within the last quarter:

Benzinga

Biomarin Pharmaceutical Earnings Preview

Biomarin Pharmaceutical (NASDAQ:BMRN) is set to give its latest quarterly earnings report on Wednesday, 2022-04-27. Here's what investors need to know before the announcement. Analysts estimate that Biomarin Pharmaceutical will report an earnings per share (EPS) of $0.17.

Benzinga

Moderna Whale Trades For April 26

Someone with a lot of money to spend has taken a bearish stance on Moderna (NASDAQ:MRNA). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Why Investing In Stocks Makes You Better At Cryptos: Part 2

Welcome to part two of this three-part series. In part one, we looked at the importance of timing and identifying high-probability assets across all markets.

Benzinga

Earnings Preview: Kraft Heinz

Kraft Heinz (NASDAQ:KHC) is set to give its latest quarterly earnings report on Wednesday, 2022-04-27. Here's what investors need to know before the announcement. Analysts estimate that Kraft Heinz will report an earnings per share (EPS) of $0.53.

Benzinga

Nvidia Continues To Slide But Here's Why A Bounce Is Imminent

Nvidia Corporation (NASDAQ: NVDA) was sliding almost 5% lower on Tuesday in sympathy with the S&P 500, which was trading about 1.7%.

Benzinga

Alkermes's Earnings Outlook

Alkermes (NASDAQ:ALKS) is set to give its latest quarterly earnings report on Wednesday, 2022-04-27. Here's what investors need to know before the announcement. Analysts estimate that Alkermes will report an earnings per share (EPS) of $0.01.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Enphase Energy Whale Trades For April 26

A whale with a lot of money to spend has taken a noticeably bearish stance on Enphase Energy. Looking at options history for Enphase Energy (NASDAQ:ENPH) we detected 12 strange trades.

Benzinga

Analyzing Micron Technology Inc's Short Interest

Micron Technology Inc's (NASDAQ:MU) short percent of float has risen 7.21% since its last report. The company recently reported that it has 24.71 million shares sold short, which is 2.23% of all regular shares that are available for trading.

Benzinga

Looking Into Coinbase Global Inc. - Class A Common Stock's Recent Short Interest

Coinbase Global Inc. - Class A Common Stock's (NASDAQ:COIN) short percent of float has fallen 8.03% since its last report. The company recently reported that it has 6.15 million shares sold short, which is 4.24% of all regular shares that are available for trading.

Benzinga

Why Amazon Shares Are Falling

Shares of large-cap US stocks, including Amazon.com, Inc. (NASDAQ: AMZN), are trading lower amid overall market weakness as Fed rate hike outlook and economic concerns weigh on market sentiment.

Benzinga

Phio Pharmaceuticals Open enrollment in Phase 1b Trial of PH-762 for the Treatment of Advanced Melanoma

Phio Pharmaceuticals Corp. (NASDAQ: PHIO) has started enrolling patients in the Phase 1b clinical trial of PH-762 for the treatment of advanced melanoma.

Benzinga

Why Warner Bros. Discovery Shares Are Falling

Warner Bros. Discovery Inc (NASDAQ: WBD) shares are trading lower by 4.91% at $20.44 after the company reported first-quarter financial results.

Benzinga

Analysis: Will Elon Musk's Twitter Kowtow To Chinese Communist Party Influence?

When Elon Musk first notified the U.S.

1 … 644 645 646 647

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Warner Bros Discovery

Chinese Communist Party

193 stories

ENPH

117 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.